Investor · Cambridge, MA

Damia Tormo

Open Damia in the network graph →

Filings

14

SEC Form D

Connections

64

co-filers

Capital

$5.0M

across filings

Active

Nov 2014

to Dec 2015

Most-connected co-filers (64)

Vaibhav Nalwaya · Boston, MA6 shared Deepak Sindwani · New York, NY6 shared Brian Kostka · Chester, PA6 shared James Krieg · Chester, PA6 shared Richard Summerbell · Calgary, Alberta, Canada6 shared Javier Garcia · Cambridge, MA4 shared Gino M. Santini · Cambridge, MA4 shared Robert M. Armstrong, Ph.D · Cambridge, MA3 shared Zhenfu Li · Beijing, Israel2 shared Peter B. Finn · Boston, MA2 shared Jonathan Terbell · Boston, MA2 shared Two Sigma Investments, LLC · NEW YORK, NY2 shared Matthew W. Clary · CHICAGO, IL2 shared Antonio Sierra · Washington, Washington, D.C.2 shared Jiri S. Novak · San Francisco, CA2 shared Kathryn A. Hall · San Francisco, CA2 shared Theodore Clark · Boston, MA2 shared Reginald S. Van Lee · San Francisco, CA2 shared Gregory W. Link · GRAND CAYMAN, Cayman Islands2 shared Alan E. Walts · Cambridge, MA2 shared Bonnie Gurry · New York, NY2 shared Ad Oliver · Diemen, P72 shared Karim Fadel · Cambridge, MA2 shared Gino Santini · Boston, MA2 shared

Recent filings (14)

Artax Biopharma, Inc.Aug 2024 · 22 co-filers$8.0M Wavecrest Growth Partners Cardata SPV, L.P.Sep 2023 · 8 co-filers$31.3M Wavecrest Growth Partners Impel Opportunities Fund, L.P.Dec 2022 · 7 co-filers Wavecrest Growth Partners II, L.P.May 2021 · 5 co-filers$290.0M Wavecrest Growth Partners Pole Star SPV, L.P.Mar 2021 · 5 co-filers$14.7M Artax Biopharma, Inc.Feb 2021 · 14 co-filers$3.0M FourBridge Partners, 2021, L.P.Oct 2020 · 8 co-filers$50.0M Wavecrest Growth Partners Volante SPV, L.P.Jul 2020 · 5 co-filers$8.4M FourBridge Partners, 2020, L.P.Mar 2020 · 8 co-filers$40.0M Wavecrest Growth Partners EDITED SPV, L.P.Mar 2020 · 5 co-filers$4.5M GL China Opportunities Fund II L.P.Dec 2015 · 12 co-filers$600.0M Artax Biopharma, Inc.Oct 2015 · 16 co-filers$10.0M GL China Opportunities Fund II L.P.Dec 2014 · 12 co-filers$600.0M Artax Biopharma, Inc.Nov 2014 · 13 co-filers$2.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Damia in the interactive graph →